Skip to content

Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery

Interruptions in the Coagulationsystem in Relation With Cardiac Surgery -A Randomized Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01462968
Enrollment
0
Registered
2011-11-01
Start date
2011-11-30
Completion date
2012-03-31
Last updated
2015-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Keywords

Heparin treatment during cardiac surgery, Heparin reversal after cardiac surgery, Thrombin generation, Endogenous Thrombin potential

Brief summary

The purpose of this study is to find the heparinization method, which 1. affect the heparin-protaminsulfate ratio in the best way to achieve haemostasis 2. gives the smallest change in endogenous thrombin potential (ETP)postoperative compared to preoperative (deltaETP) as an indicator for haemostatic activation during cardiac surgery. The hypothesis is that the deltaETP is larger in the Haemochron Signature Elite group than in the Hepcon-group because of the heparinization-method. Therefore there is a potential higher risk for use of bloodproducts postoperatively.

Interventions

DEVICEActivated clotting time versus blood-heparin concentration

Activated clotting time used for heparinization strategy during cardiag surgery versus blood-heparin concentration

Sponsors

Medtronic
CollaboratorINDUSTRY
Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective on-pump coronary artery bypass grafting (CABG) single procedure * Elective aortavalve replacement (AVR) (single procedure)

Exclusion criteria

* Emergency procedures * Children and youngsters less than 18 years * Pregnancy * Less than 2 days break with platelet inhibiting drugs (acetylsalicylic acid, NSAID, clopidogrel, serotonin reuptake inhibitors) * Less than 2 days break with AC-treatment (warfarin, heparin, coumarin etc) * Known coagulopathy * Endocarditis * Preoperative anaemia * Dialysis patients

Design outcomes

Primary

MeasureTime frameDescription
Delta ThrombingenerationTimeframe is from Start of surgery to 4 hours after end of surgery, average time 9 hours.Postoperative versus preoperative thrombingeneration evaluated by Endogenous Thrombin Potential,peak Thrombin level and Lagtime by using a Thromboscope

Secondary

MeasureTime frameDescription
Platelet functionTimeframe is from Start of surgery to 4 hours after end of surgery, average time 9 hours.Platelet aggregation measured by Multiplate platelet function analyzer
peroperative heparine/protaminesulphate ratioThe timeframe is from the first heparin is given to the neutralization with protamine sulfate, average time 4 hours
ThromboelastometryTimeframe is from Start of surgery to 4 hours after end of surgery, average time 9 hours.We are looking at the parameters: Clottingtime, Clot formation time and maximum velocity,maximum clot firmness
Standard coagulationtestsTimeframe is from Start of surgery to 4 hours after end of surgery, average time 9 hours.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026